Alendronate (Fosamax) Drug-Drug Interactions: Complete Clinical Profile
Evidence-based guide to every clinically significant alendronate drug interaction, including calcium, NSAIDs, PPIs, and glucocorticoids, with dosing strategies to minimize risk.
Alendronate
22 source-based articles maintained by the HealthRX.com Editorial Team.
22articles
5topic areas covered
May 25, 2026latest review
Alendronate library
Showing 22 of 22 clinical reviews.
Fosamax (Alendronate) Food and Supplement Interactions: What to Take, What to Avoid, and When
A clinical guide to alendronate food and supplement interactions, including calcium timing, mineral interference, and evidence-based dosing strategies to protect bioavailability.
Fosamax (Alendronate): What to Expect Week by Week in Your First Month
A week-by-week guide to alendronate (Fosamax) in the first month, covering GI side effects, dosing technique, bone-marker changes, and what improvement actually looks like at 4 weeks.
Fosamax Appetite & Cravings Changes: What the Clinical Evidence Actually Shows
Does alendronate (Fosamax) affect appetite or food cravings? An evidence-based breakdown of GI mechanisms, clinical trial data, and practical management for patients taking alendronate for osteoporosis.
Fosamax Autoimmune Disease Considerations: What Clinicians and Patients Need to Know
An evidence-based guide to alendronate (Fosamax) use in patients with autoimmune diseases, covering bisphosphonate interactions with immune function, GI risk, osteonecrosis, and dosing decisions.
Fosamax Cognitive Function Impact: What the Evidence Actually Shows
A clinician-level review of alendronate (Fosamax) and cognitive function, covering mechanistic hypotheses, observational data, and what current guidelines say about bisphosphonate use in older adults.
Fosamax Dosing in Renal Impairment: What Prescribers Need to Know
A clinician-level guide to alendronate (Fosamax) dosing in renal impairment, covering mechanism, pharmacokinetics, the FIT trial, and evidence-based thresholds for dose adjustment or avoidance.
Fosamax Hair and Skin Changes: What Alendronate Actually Does to Integument
A deep dive into alendronate (Fosamax) hair and skin side effects, including postmarketing case reports, mechanism, and clinical management guidance.
Fosamax Half-Life: Plasma vs Bone Retention Explained
Alendronate's plasma half-life is around 1 hour, but it binds bone for over 10 years, explaining its long-lasting effect on osteoclasts after dosing stops.
Fosamax History and Development: How Alendronate Changed Osteoporosis Treatment
A clinical history of alendronate (Fosamax), from Merck's laboratory synthesis through the FIT trial, FDA approval, weekly dosing, patent expiration, and its current role in osteoporosis care.
Fosamax Mental Health and Mood Impact: What the Evidence Actually Shows
A clinician-level review of alendronate (Fosamax) and its reported effects on mood, depression, anxiety, and cognitive function, with primary-literature citations and a practical monitoring framework.
Fosamax Monitoring Schedule: Labs & Exams for Alendronate Therapy
Complete alendronate (Fosamax) monitoring schedule including baseline labs, follow-up bone density scans, renal function tests, and calcium checks. Evidence-based timelines for safe long-term bisphosphonate therapy.
Fosamax Patent History and Generic Alendronate Timeline
A complete timeline of Fosamax (alendronate) patents, generic entry, and current market status, with clinical context from the FIT trial and FDA approval history.
Fosamax Post-Bariatric Surgery Use: What Clinicians and Patients Need to Know
Alendronate after bariatric surgery carries significant absorption and tolerability risks. Learn which patients qualify, what alternatives exist, and how current guidelines approach bisphosphonate therapy in post-bariatric bone management.
Fosamax Pre-Surgery Hold Window: What Surgeons and Patients Need to Know About Alendronate
A clinician-level guide to the alendronate pre-surgery hold window: when to pause Fosamax, how long bone binding lasts, fracture risk versus surgical risk, and current guideline consensus.
Fosamax Renal Protection or Renal Risk: What Clinicians Need to Know
A clinician-level review of alendronate (Fosamax) and the kidneys: pharmacokinetics, renal clearance, CKD dosing thresholds, evidence from FIT and post-market data, and practical monitoring guidance.
Fosamax Safety for Adults Ages 50 to 64
Fosamax (alendronate) cuts vertebral fracture risk 47% in trials; watch for GI irritation, rare jaw issues, and femur fracture risk after 5+ years of use.
Fosamax Storage, Stability & Shelf Life: What Patients and Clinicians Need to Know
A guide to alendronate (Fosamax) storage conditions, shelf-life data, stability science, and what degradation means for fracture-risk protection.
Fosamax Travel & Timezone-Shift Protocols: Complete Clinical Guide to Alendronate Dosing on the Road
Board-reviewed protocols for taking alendronate (Fosamax) during travel, long-haul flights, and timezone crossings. Covers missed-dose rules, posture requirements at altitude, and real-world scheduling fixes backed by primary literature.
How to Safely Stop Fosamax (Alendronate): A Physician-Level Discontinuation Protocol
Evidence-based guide to safely discontinuing alendronate (Fosamax), including who qualifies for a bisphosphonate holiday, monitoring protocols, and when to restart therapy.
Missed Fosamax Dose: Use the Right Calendar for Your Prescription
Missed Fosamax? Check whether your prescription is weekly or daily, choose the right restart date, and avoid doubling up.
Switching From or To Fosamax (Alendronate): Protocols, Timing, and What the Evidence Says
Evidence-based guide to switching from alendronate (Fosamax) to other osteoporosis drugs or transitioning onto alendronate from denosumab, teriparatide, or romosozumab.